Results 161 to 170 of about 14,551 (210)

Severe Worsening of Neuropathy Associated With Antibodies Against Myelin-Associated Glycoprotein by Rituximab Resembling Chronic Inflammatory Demyelinating Polyneuropathy. [PDF]

Cureus
Dang J, Li Y.
europepmc   +1 more source

Unmasking the mimic: Leprosy neuropathy misdiagnosed as chronic inflammatory demyelinating polyneuropathy: A case report from Saudi Arabia. [PDF]

Neurosciences (Riyadh)
AlOtaibi MK, AlQahtani BG, AlQawahmed RM.   +2 more
europepmc   +1 more source

Chronic Inflammatory Demyelinating Polyneuropathy: A Narrative Review of a Systematic Diagnostic Approach to Avoid Misdiagnosis. [PDF]

Cureus
Roman-Guzman RM, Martinez-Mayorga AP, Guzman-Martinez LD, Rodriguez-Leyva I.   +3 more
europepmc   +1 more source

Genetic susceptibility of human leukocyte antigen alleles in chronic inflammatory demyelinating polyneuropathy in Korean patients : Short title: HLA alleles and CIDP in Korea. [PDF]

BMC Neurol
Kwon S, Seok JM, Lee HL, Chung YH, Ju H, Jeon MY, Kim BJ.   +6 more
europepmc   +1 more source

Evaluating Grasp Function in Patients With Chronic Inflammatory Demyelinating Polyneuropathy Using Dynamometers: A Comprehensive Review. [PDF]

J Clin Med Res
Tsoumanis P, Chatzoglou T, Smyris TI, Stefanou C, Tsoumanis D, Stefanou S, Tepelenis K, Barbouti A, Marini A, Zafeiropoulos P, Varvarousis D.   +10 more
europepmc   +1 more source

Case Report: Staged bilateral pancarpal arthrodesis using 3D-printed patient specific guides and customized hybrid plate for severe carpal joint instability associated with chronic inflammatory demyelinating polyneuropathy in a miniature dachshund. [PDF]

Front Vet Sci
Franca A, Marco-Carpio I, Oxley B, Mínguez JJ, Vallefuoco R.   +4 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Chronic Inflammatory Demyelinating Polyneuropathy

New England Journal of Medicine, 2005
Chronic inflammatory demyelinating polyneuropathy (CIDP) is an acquired immune-mediated disease of the peripheral nervous system with a prevalence of 1-2/100,000. Clinical and experimental findings suggest a role of immune pathomechanisms;however, the target antigens are still unknown.
Hubertus, Köller, Bernd C, Kieseier, Sebastian, Jander, Hans-Peter, Hartung   +3 more
openaire   +3 more sources

Chronic inflammatory demyelinating polyneuropathy

Current Treatment Options in Neurology, 2003
Although there are close to 10 randomized trials showing efficacy for prednisone, intravenous immunoglobulin, or plasmapheresis in chronic inflammatory demyelinating polyneuropathy (CIDP), large differences in cost, side effect profiles, and ease of use create controversy over the therapy that is best.
Jonathan S., Katz, David S., Saperstein
openaire   +2 more sources

Chronic inflammatory demyelinative polyneuropathy

2013
Chronic inflammatory demyelinative polyneuropathy (CIDP) is an acquired polyneuropathy presumably of immunological origin. It is characterized by a progressive or a relapsing course with predominant motor deficit. The diagnosis rests on the association of non-length-dependent predominantly motor deficit following a progressive or a relapsing course ...
Said, Gérard, Krarup, Christian
openaire   +3 more sources